F004 Complex Medical Dermatology Cases: Pearls and Pitfalls
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Many patients present with challenging skin manifestations posing diagnostic and therapeutic dilemmas. Using a case-based approach featuring complex medical dermatoses (including alopecia areata, lupus, dermatomyositis, pyoderma gangrenosum, and hidradenitis suppurativa), this session will highlight clinical pearls in making the diagnosis and elaborating treatment regimens as well as pitfalls to avoid. Management strategies based on the latest data from the literature will be reviewed, in addition to useful novel diagnostic tests.
LEARNING OBJECTIVES
Recognize subtleties in clinical presentation when formulating differential diagnoses in select complex medical dermatoses
Apply "tricks of the trade" when elaborating a management plan for treating select complex medical dermatoses
SPEAKERS
Leslie Castelo-Soccio, MD, PhD, FAAD
Alexandra P Charrow, MD, FAAD
Benjamin F. Chong, MD, MSc, FAAD
Christina Lam, MD, FAAD
Robert Micheletti, MD, FAAD
Ruth Ann Vleugels, MD, MBA, MPH, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Leslie Castelo-Soccio, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Alexandra P Charrow, MD, FAAD
Avalo – Consultant (1099 relationship)(Fees); Dermatology Foundation – Investigator(Grants/Research Funding); Hidradenitis Suppurativa Foundation – Board of Directors(No Compensation Received), Investigator(Grants/Research Funding); Incyte Corporation – Advisory Board(Fees), Investigator(No Compensation Received); Insmed – Investigator(No Compensation Received); Insmed Incorporated – Investigator(No Compensation Received); Novartis Pharmaceuticals Corp. – Advisory Board(Fees); Q32 Bio Inc. – Consultant (1099 relationship)(No Compensation Received); Sonoma Biotherapeutics – Investigator(No Compensation Received); UCB Pharma – Advisory Board(Honoraria); Wedbush Securities – Consultant (1099 relationship)(Honoraria);
Benjamin F. Chong, MD, MSc, FAAD
Amgen – Other(Honoraria); AstraZeneca – Consultant (1099 relationship)(Fees); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Cesas Medical Limited – Speaker(Honoraria); EMD Serono – Consultant(Honoraria), Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Consultant(Honoraria); Lupus Research Alliance – Consultant (1099 relationship)(Honoraria); MAPI Research Trust – Other(Patent royalties or other compensation for Intellectual Property Rights); Pfizer Inc. – Investigator(Grants/Research Funding);
Christina Lam, MD, FAAD
Biogen – Consultant (1099 relationship)(Fees), Investigator(Fees);
Robert Micheletti, MD, FAAD
Acelyrin – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding); Cabaletta Bio – Investigator(Grants/Research Funding); InflaRx – Investigator(Grants/Research Funding); Vertex Pharmaceuticals, Inc. – Consultant(Fees);
Ruth Ann Vleugels, MD, MBA, MPH, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Consultant (1099 relationship)(Honoraria); BMS – Consultant (1099 relationship)(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria);